Department of Ophthalmology, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany.
Department of Medicine, Surgery and Dentistry, University of Salerno, Via S. Allende, 84081, Baronissi, SA, Italy.
Front Med. 2022 Dec;16(6):975-983. doi: 10.1007/s11684-022-0923-4. Epub 2022 Sep 24.
The effectiveness of using acupuncture for dry eye disease (DED) is controversial. Thus, this systematic review investigated the effectiveness and feasibility of using acupuncture for DED in accordance with the 2020 PRISMA statement. The outcomes of interests were (1) to evaluate the efficacy of acupuncture in improving the ocular surface disease index (OSDI), Schirmer I test score, and tear breakup time from baseline to the last follow-up; (2) to determine possible complications of using acupuncture; and (3) to investigate the superiority of acupuncture over other commonly used treatments for DED. Data from 394 patients were collected. Results showed that acupuncture significantly prolonged the tear breakup time (P < 0.0001), significantly increased the Schirmer I test score (P < 0.0001), and significantly reduced the OSDI (P < 0.0001) from baseline to the last follow-up. Compared with the control group, the acupuncture group had significantly greater Schirmer I test score (P < 0.0001), significantly longer tear breakup time (P = 0.0004), and significantly lower OSDI (P = 0.002). These results suggest that acupuncture is effective and feasible in improving symptoms and signs of DED. No severe adverse effects of acupuncture were observed.
针刺治疗干眼症(DED)的疗效存在争议。因此,本系统评价按照 2020 年 PRISMA 声明,调查针刺治疗 DED 的有效性和可行性。主要结局指标为:(1)评估针刺治疗从基线至末次随访时改善眼表疾病指数(OSDI)、泪液分泌试验(Schirmer I 试验)评分和泪膜破裂时间(BUT)的疗效;(2)确定针刺治疗的可能并发症;(3)调查针刺治疗与 DED 常用治疗方法相比的优势。共纳入 394 例患者的数据。结果显示,针刺治疗从基线至末次随访时明显延长 BUT(P < 0.0001),明显增加 Schirmer I 试验评分(P < 0.0001),明显降低 OSDI(P < 0.0001)。与对照组相比,针刺组的 Schirmer I 试验评分明显更高(P < 0.0001),BUT 明显更长(P = 0.0004),OSDI 明显更低(P = 0.002)。这些结果表明,针刺治疗可有效改善 DED 的症状和体征,且安全性良好。未观察到针刺治疗的严重不良事件。